Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schneiderman, J. H.
Right arrow Articles by Schwartzkroin, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schneiderman, J. H.
Right arrow Articles by Schwartzkroin, P. A.
NEUROLOGY 1982;32:730
© 1982 American Academy of Neurology

Effects of phenytoin on normal activity and on penicillin-induced bursting in the guinea pig hippocampal slice

J. H. Schneiderman, M.D. and P. A. Schwartzkroin, Ph.D.

Department of Neurological Surgery, University of Washington, Seattle, WA.

We used both intracellular and field potential recordings to study the effects of phenytoin (20 to 40 µg per milliliter) on CA3 and CA1 neurons of guinea pig hippocampal slices, with or without exposure to the convulsant sodium penicillin G. Phenytoin did not change resting membrane potential, input resistance, action potential amplitude or duration, or the threshold intensity for activating action potentials or bursts with intracellular current pulses. Suppression of penicillin-induced bursting was associated with an increased threshold for orthodromically activating neurons. The intrinsic bursting mechanisms of the cells remained intact. Phenytoin seemed to suppress penicillin-induced epileptiform activity by decreasing synaptic transmission.

Address correspondence and reprint requests to Dr. Schneiderman, Room 115–116, E. K. Jones Building, Wellesley Hospital. 160 Wellesley Street East, Toronto, Ontario M4Y 1J3, Canada.

Dr. Schneiderman was supported by a fellowship from the Medical Research Council of Canada. This work was supported by grants Nos. NS00413 and NS-04053 from the National Institute of Neurological and Communicative Disorders and Stroke. National Institute of Health, Dr. Schwartzkroin is an affiliate of the Child Development and Mental Retardation Center, University of Washington.

Presented at the thirty-third annual meeting of the American Academy of Neurology. Toronto. Canada, April 1981.

Accepted for publication November 10, 1981.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by AAN Enterprises, Inc.